Charles A. Rowland Jr.
At a glance: Charles A. Rowland Jr. is Director at Viking Therapeutics (VKTX). Their latest SEC Form 4, filed Oct 28, 2025, reported a sale of $2.1M. On file: 0 purchase lines ($0) and 1 sale line ($2.1M).
Disclosed holdings: about $776K of VKTX stock: 30,000 shares reported on their latest Form 4 (filed Oct 28, 2025), valued at the Nov 19, 2026 close of $25.86. This counts only VKTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Viking Therapeutics, Inc. (VKTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Charles A. Rowland Jr.'s InsiderPrint
7 trades from SEC Form 4 filings, 2020 to 2025, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $253K a trade.
- Bump outward: a purchase (6)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Joshua G. JamesCEO · HUCK · 100% match
- Max H. MitchellCEO, President · CR · 99% match
- Charles M. SonstebyDirector · DRI · 99% match
- Harriet EdelmanDirector · EAT · 98% match
- David ZinsnerCFO · INTC · 98% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 28SEC | VKTXViking Therapeutics, Inc. | Sell | 60,00030,000 held (−67%) | $35.57 | $2.1M | -27.3% |
- Sell
Director Charles A Rowland Jr. sold $2.1M of VKTX at $35.57 — cuts the stake by 67%.
Follow Charles A. Rowland Jr.
Get one email when Charles A. Rowland Jr. files a new purchase or sale. Free.
At most one email a day about Charles A. Rowland Jr., plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.